amobarbital has been researched along with Gelineau Syndrome in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four of the 10 catatonia-type patients had resolution of their symptoms without recurrence." | 1.26 | The emergency amobarbital interview. ( Iserson, KV, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iserson, KV | 1 |
| Oswald, I | 1 |
2 other studies available for amobarbital and Gelineau Syndrome
| Article | Year |
|---|---|
The emergency amobarbital interview.
Topics: Adult; Amobarbital; Catatonia; Conversion Disorder; Emergencies; Female; Humans; Interview, Psycholo | 1980 |
Sleep.
Topics: Amobarbital; Appetite Depressants; Barbiturates; Dreams; Electroencephalography; Fenfluramine; Fluor | 1969 |